Literature DB >> 8269941

Ser2 is the autophosphorylation site in the beta subunit from bicistronically expressed human casein kinase-2 and from native rat liver casein kinase-2 beta.

B Boldyreff1, P James, W Staudenmann, O G Issinger.   

Abstract

Human casein kinase-2 (CK-2) subunits alpha and beta were bicistronically expressed in bacteria. The recombinant holoenzyme shared all investigated properties with the native CK-2 from mammalian sources (rat liver, Krebs II mouse ascites tumour cells). Contrary to recombinant human CK-2 produced by self-assembly in vitro, the bicistronically expressed beta subunit was autophosphorylated during formation of the holoenzyme in bacteria. Electrospray ionisation mass spectrometry (ESI) revealed Ser2 (second amino acid, first serine) as the only phosphate acceptor site. Kinetic data obtained with either the phosphorylated or the unphosphorylated form of CK-2 did not differ significantly, suggesting that the autophosphorylation had no influence on the kinetic parameters Km and Vmax. In parallel, native rat liver CK-2 beta subunit was shown to incorporate 0.1 mol phosphate/mol holoenzyme, which suggests that the enzyme is already heavily phosphorylated. ESI analysis also revealed Ser2 as the only phosphorylated residue at the amino terminus. In the case of both recombinant human CK-2 and native rat liver CK-2, treatment with alkaline phosphatase readily reversed the phosphorylated form of the beta subunit to the faster migrating dephosphorylated polypeptide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8269941     DOI: 10.1111/j.1432-1033.1993.tb18404.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Expression and regulation of protein kinase CK2 during the cell cycle.

Authors:  D G Bosc; B Lüscher; D W Litchfield
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Isolation of a CK2α subunit and the holoenzyme from the mussel Mytilus galloprovincialis and construction of the CK2α and CK2β cDNAs.

Authors:  Regina-Maria Kolaiti; Andrea Baier; Ryszard Szyszka; Sophia Kouyanou-Koutsoukou
Journal:  Mar Biotechnol (NY)       Date:  2010-10-05       Impact factor: 3.619

Review 3.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

Authors:  David W Litchfield
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

4.  Autophosphorylation at the regulatory beta subunit reflects the supramolecular organization of protein kinase CK2.

Authors:  Mario A Pagano; Stefania Sarno; Giorgia Poletto; Giorgio Cozza; Lorenzo A Pinna; Flavio Meggio
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

5.  Crystal structure of the human protein kinase CK2 regulatory subunit reveals its zinc finger-mediated dimerization.

Authors:  L Chantalat; D Leroy; O Filhol; A Nueda; M J Benitez; E M Chambaz; C Cochet; O Dideberg
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

6.  Immunologically defined subclasses of the protein kinase CK2 beta-subunit in prostate carcinoma cell lines.

Authors:  Claudia Götz; Sabine Kartarius; Sarah Schetting; Mathias Montenarh
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

7.  Biochemical characterization of CK2alpha and alpha' paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2alpha'-holoenzyme forming trimeric complexes.

Authors:  Birgitte B Olsen; Tine Rasmussen; Karsten Niefind; Olaf-Georg Issinger
Journal:  Mol Cell Biochem       Date:  2008-06-24       Impact factor: 3.396

8.  The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2beta.

Authors:  Ashley C Bibby; David W Litchfield
Journal:  Int J Biol Sci       Date:  2005-04-01       Impact factor: 6.580

Review 9.  Drosophila Protein Kinase CK2: Genetics, Regulatory Complexity and Emerging Roles during Development.

Authors:  Mohna Bandyopadhyay; Scott Arbet; Clifton P Bishop; Ashok P Bidwai
Journal:  Pharmaceuticals (Basel)       Date:  2016-12-29

Review 10.  The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design.

Authors:  Giorgio Cozza
Journal:  Pharmaceuticals (Basel)       Date:  2017-02-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.